AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
Clinical trial NCT04430036 · TERMINATED
Trial details
- NCT number
- NCT04430036
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2021-10-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.